BIVDA Press Releases

Mar 02, 2021
BIVDA calls for a diagnostics industry of ‘critical mass’ to help fight future health challenges  BIVDA, the trade association for British in-vitro diagnostic companies, has submitted a response to the Government’s new Innovation Taskforce, set up by the Prime Minister to identify and develop proposals across a range of areas that will drive innovation and competitiveness, reduce barriers to start-ups and scale-ups, create opportunities for innovation to make the most of c...
Read More
Feb 24, 2021
NHSEI SBRI Healthcare grant for Psyros’ rapid, ultra-sensitive test for heart attack marker Firm raising £2.5m seed round to support further development of prototypeDiscovery Park, Sandwich, UK, February 24 2021 – Psyros Diagnostics, which is developing ultra-sensitive, ultra-fast, point of care diagnostics based on single molecule counting, has been awarded a £99,400 grant by NHSEI SBRI Healthcare1 to advance their novel test for the heart attack marker troponin. Ps...
Read More
Feb 23, 2021
RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY Randox Laboratories has confirmed that it has processed its 10 millionth sample for the UK’s COVID-19 National Testing Programme, making it the first Pillar 2 testing laboratory to achieve this milestone.  This achievement is based upon a £85 million investment since March 2020 in facilities and equipment at Randox’s laboratories in Northern Ireland.  As a key partner labor...
Read More
Feb 22, 2021
BIVDA calls for investment in diagnostics to help make Britain a science superpower BIVDA, the in-vitro diagnostics trade association, has called for an economic recovery based on developing the UK as a science superpower, with a policy focus on advanced manufacturing, research & innovation, and highly skilled jobs. In its submission to Rishi Sunak, the trade association identifies three priorities for investment in the Chancellor’s financial package next month; Investment in...
Read More
Feb 18, 2021
HORIBA Medical Obtains CE Mark Certification for Microsemi CRP New Generation - Microsemi CRP LC-767G HORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G. This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity pr...
Read More
Feb 17, 2021
Revolutionise Your Pancreatic Elastase Testing with the New BÜHLMANN fPELA® turboFaecal pancreatic elastase testing can now be automated, providing flexible and random access application on most clinical chemistry platforms. The new fPELA® turbo from BÜHLMANN is ideal for use in laboratory environments for identification and monitoring of pancreatic insufficiency in patients. There is the added advantage that it utilises the same CALEX extraction device as the fCAL turbo assay,...
Read More
Feb 15, 2021
BIVDA comments on Life Science Competitiveness Report BIVDA has welcomed the publication of the Life Science Competitiveness Indicators 2020, a report that gives a comprehensive outline of the state of the UK life sciences sector covering research funding, import-export levels and investment, amongst other key indicators. Life sciences continue to be a crucial pillar of the UK economy generating almost £81bn annually and employing over 250,000 people. In terms of Government activ...
Read More
Feb 11, 2021
BIVDA Comments on Health and Care White Paper BIVDA Chief Executive Doris-Ann Williams and Chief Operating Officer Helen Dent have commented on the publication of the Health and Care White Paper by the Health Secretary Matt Hancock.  Commenting on plans to promote integrated care in the health service, Doris-Ann said; “The new White Paper offers an opportunity to promote joint working and collaboration in the NHS across different teams, department and disciplines. As part of...
Read More
Feb 04, 2021
Please see below a press release from BIVDA on the publication of the Accelerated Access Collaborative’s Our Year in Focus Report. ---  BIVDA welcomes publication of Accelerated Access Collaborative’s Our Year in Focus Report The impact that new innovations has had on the NHS is set out in the Accelerated Access Collaborative’s (AAC) report, Our Year in Focus 2019/20 which BIVDA has welcomed today. The report reveals how over 700,000 patients were provi...
Read More
Feb 03, 2021
03/02/21   CRYOcheck™ Lupus Anti-Coagulant Testing Solutions for Every Stage of the Testing Pathway For laboratories wishing to perform accurate testing for Lupus Anti-Coagulant (LA), the cryocheck™ frozen controls and reagents provide solutions to fit every stage of the pathway - screen, mix, confirm and quality control.   Available in the UK exclusively from Alpha Laboratories, these products, developed by ...
Read More
Page 3 of 11 [3]